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Abstract
An enteroaggregative Verotoxin (Vtx)-producing Escherichia coli strain of serotype O104:H4 has recently been
associated with an outbreak of haemolytic-uremic syndrome and bloody diarrhoea in humans mainly in Germany,
but also in 14 other European countries, USA and Canada. This O104:H4 E. coli strain has often been described as
an enterohaemorrhagic E. coli (EHEC), i.e. a Vtx-producing E. coli with attaching and effacing properties. Although
both EHEC and the German O104:H4 E. coli strains indeed produce Vtx, they nevertheless differ in several other
virulence traits, as well as in epidemiological characteristics. For instance, the primary sources and vehicles of
typical EHEC infections in humans are ruminants, whereas no animal reservoir has been identified for
enteroaggregative E. coli (EAggEC). The present article is introduced by a brief overview of the main characteristics
of Vtx-producing E. coli and EAggEC. Thereafter, the O104:H4 E. coli outbreak is compared to typical EHEC
outbreaks and the virulence factors and host specificity of EHEC and EAggEC are discussed. Finally, a renewed
nomenclature of Vtx-producing E. coli is proposed to avoid more confusion in communication during future
outbreaks and to replace the acronym EHEC that only refers to a clinical condition.
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Introduction
Escherichia coli is a well-known Gram-negative, rod-
shaped bacterium belonging to the family Enterobacter-
iaceae that readily grows on simple bacteriological
media. While many strains occur as commensal mem-
bers of the microbiota in the intestinal tract of animals
and humans, some strains are, however, important
pathogens, that cause a wide spectrum of diseases, ran-
ging from self-limiting to life-threatening intestinal and
extra-intestinal illnesses, like enteritis, enterotoxaemia,
cystitis, pyelonephritis, meningitis, mastitis, arthritis, and
septicaemia [1-3].
Many pathogenic E. coli are host-adapted and only a
limited number of strains infecting animals are able to
cause disease in humans. These strains, however, are more
likely to get the attention of the scientific community and
of the news media. A typical example of zoonotic E. coli is
the O157:H7 serotype that can be responsible for two
severe syndromes in humans, haemorrhagic colitis (HC)
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voir is the intestinal tract of healthy cattle and other rumi-
nants [1,4,5]. The hallmark of these “enterohaemorrhagic
E. coli“ ("EHEC”) strains is the production of cytotoxins
called Vero(cyto)toxins (Vtx) or Shiga toxins (Stx), two
synonyms for the same group of toxins referring either to
their toxicity for Vero cells [6] or to their homology with
the Shiga toxin produced by Shigella dysenteriae type 1
[7]. Another key property of O157:H7 “EHEC” strains is
the production of the ultrastructural “Attaching and Effa-
cing” (AE) lesion [1,4,5]. Although E. coli strains “posses-
sing the same clinical, epidemiological and pathogenic
properties as O157:H7 strains” in humans can also be
designed as “enterohaemorrhagic E. coli“ [8], the essential
genetic features that define organisms capable of causing
either HC or HUS clinical syndromes are not clear [3,9].
In May 2011, the Robert Koch Institute (Berlin, Ger-
m a n y )i s s u e da na l e r to na ni n c r e a s eo ft h en u m b e ro f
cases of HC and HUS observed in Germany. Though
such clinical signs are often associated with “EHEC”
infections, laboratory investigations pointed out that this
outbreak was caused by a strain of serotype O104:H4
combining the adherence properties of enteroaggregative
E. coli (EAggEC) and the production of Vtx, but negative
for the AE lesion; therefore not corresponding to the
above definition of “EHEC”. Nevertheless the O104:H4
strain was often described as an “EHEC bacterium” in the
media, on different internet sites and in scientific publi-
cations [10,11], adding to the confusion and misleading
information during the outbr e a k ,a . o .a b o u tt h ea c t u a l
origin of the bacterium, since “EHEC” outbreaks are
most often of animal origin while no animal reservoir has
ever been identified for EAggEC [1,4,5].
The purpose of this manuscript is therefore to explain
the actual situation to the medical and veterinarian pro-
fessions by (i) comparing the epidemiology and clinical
data of the O104:H4 strain outbreak with the classical
O157:H7 “EHEC” outbreaks; and (ii) describing the most
important virulence properties of Vtx-producing E. coli
(VTEC) and of EAggEC, with emphasis on those involved
in host specificity. In a final section, an adapted nomen-
clature of VTEC is proposed to avoid more confusion in
the future if strains combining Vtx-production with
other virulence factors are described. But at first the dif-
ferent VTEC and EAggEC strains will be briefly
described.
Verotoxin-producing and enteroaggregative E. coli
The pathogenic strains of E. coli p r o d u c es p e c i f i cv i r u -
lence factors that facilitate their interactions with the tar-
get host: colonization of the epithelial surfaces, crossing
of the mucosal barriers, invasion of the blood stream and
internal organs, and/or production of toxins causing cel-
lular and tissue damages leading to organ dysfunction,
clinical signs, symptoms and diseases. They are grouped
in so-called “pathotypes” (or “virulotypes”)o nt h eb a s i s
of four criteria: the clinical syndrome, the target species,
the adherence factors, and/or the production of exotox-
ins (Table 1). Several review articles on the E. coli patho-
types in humans and animals have been published
[1,2,4,12,13]. Only the VTEC and EAggEC pathotypes of
interest for this manuscript are described in some details
hereunder.
Verotoxin-producing E. coli with attaching and effacing
properties
VTEC are defined by the production of cytotoxins killing
Vero and some other (HeLa, HEp-II, MDBK) cell lines
(Figure 1), designated by two synonymous names, Vero-
toxins (Vtx) or Shiga toxins (Stx). The acronym “EHEC”
was proposed by Nataro and Kaper [4] for all VTEC, dis-
tinguishing “typical EHEC” that produce the AE lesion
on enterocytes (Figure 2) and “atypical EHEC” that do
not. The same authors later considered that “EHEC” are
a subgroup of only AE-positive VTEC [1]. But not all
authors actually agree on the definition of this acronym
“EHEC” [1,2,4,12,13] and, as a consequence, the range of
E. coli strains covered by this acronym varies in the scien-
tific literature. Moreover AE lesions are also produced by
enteropathogenic E. coli (EPEC) that produce no Vtx
[14,17,18] (Table 1) and some authors still group
together AE lesion-producing VTEC and EPEC under
the name “Attaching Effacing E. coli“ (acronym AEEC)
[19] adding to the confusion of the nomenclature. There-
fore to avoid any confusion in this manuscript the acro-
nym “EHEC” will be disregarded and replaced by the
acronym “AE-VTEC”.
AE-VTEC are responsible for uncomplicated diarrhoea
and HC in humans, sometimes progressing to HUS or in
adults to thrombotic-thrombocytopenic purpura (TTP).
Both HUS and TTP syndromes include microangiopathic
anaemia, thrombocytopenia, renal failure and often cen-
tral nervous system involvement [5,21]. In summary the
AE lesion is responsible for the non-haemorrhagic enteri-
tis, while the Vtx are responsible for HC, HUS and TTP.
AE-VTEC strains belonging to serotype O157:H7 have
the highest epidemiological and clinical incidence and
are the most frequently involved in severe and large out-
breaks (seropathotype group A) [22]. Other clinically
important AE-VTEC serotypes, also causing severe dis-
eases in humans and involved in outbreaks though less
frequently, are O26:H11, O103:H2, O111:H-, O121:H19,
and O145:H- (seropathotype group B) [22].
AE-VTEC are primarily human pathogens, but they are
also of interest for veterinarians because their main reser-
voir hosts are the ruminants, including cattle, sheep,
goats, and cervids, which are asymptomatic carriers. In
many cases, human infection occurs via consumption of
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Page 2 of 12Table 1 Definition, host range and virulence properties of enteric and enterotoxaemic E. coli in animals and humans (from [1,2,4,12-16])
Name (Acronym) * Target host
range
Diseases Virulence Remarks
Enteroinvasive (EIEC) Humans, primates Dysentery Invasion of and multiplication in the enterocytes Similar to Shigella sp.
Enterotoxigenic (ETEC) Pigs, ruminants,
humans (more
rarely dogs)
Traveller’s diarrhoea; profuse neonatal diarrhoea
in babies, calves and piglets; post-weaning
diarrhoea in piglets
Fimbrial adhesins (F2 to F6, F17, F18, F41, ...); heat-
stable (STa, STb) and heat-labile (LT1, LT2)
enterotoxins
Enteropathogenic
(EPEC)
Humans, all
mammals
Diarrhoea Attaching and effacing (AE) lesion; type 4 BFP
fimbriae by typical (t) EPEC of humans
Localized adherence (LA) of tEPEC on cells in
culture; LA-like adherence of atypical (a) EPEC at
the cell surface
Verotoxigenic or
Shigatoxigenic (VTEC or
STEC) *
Humans, piglets Haemolytic-uremic syndrome (HUS) in humans;
oedema disease in piglets
Verotoxins (Vtx); afimbrial (Saa by human or AIDA
by porcine VTEC) and fimbrial (F18 by porcine
VTEC) adhesins
Ruminants can be healthy carriers of human
VTEC (= reservoir host)
Enterohaemorrhagic
(EHEC) *
Humans (haemorrhagic) colitis and HUS in humans;
diarrhoea in young calves
Vtx and AE lesion Ruminants can be healthy carriers of human
EHEC (= reservoir host)
Enteroadherent or
Enteroaggregative
(EAEC or EAggEC)
Humans
(sporadically in
animals)
Diarrhoea Human EAggEC: small fimbrial adhesins (AAF/Hda);
toxins (Pet, EAST1, ShET1); transcriptional activator
gene (aggR)
Aggregative “stacked brick” adherence (AggA)
on cells in culture; animal EAggEC are different
from human EAggEC
Diffusely adherent
(DAEC)
Humans, animals Diarrhoea; extra-intestinal infections (urinary
tract infections, septicaemia)
Diffuse adherence (DA) on cell culture mediated
by adhesins of the AFimbrial Adhesin (AFA) family,
or by AIDA adhesin
Necrotoxigenic (NTEC) Humans, animals
(NTEC1); ruminants
(NTEC2)
Diarrhoea; extra-intestinal infections (urinary
tract infections, septicaemia)
Cytotoxic Necrotizing Factors (CNF) 1 or 2; different
fimbrial (Pap, Sfa and/or F17) and/or afimbrial
adhesins (AFA family)
* see Introduction and Section 2.1 for the definitions of the names and acronyms of pathogenic E. coli strains.
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2Figure 2 Attaching and effacing (AE) lesions produced by a canine enteropathogenic E. coli (EPEC) in the ligated loop intestinal assay
in rabbit. Healthy enterocyte with microvillus layer (left); AE lesion (right) from [20]: a) few “surviving” microvilli; b) intimately adherent E. coli;c )
pedestal formation beneath the adherent bacteria; d) sometimes internalization of the bacteria into the enterocytes.
Figure 1 Cytotoxic effect of Verotoxin (Vtx) 1 produced by an O157:H7 AE-VTEC. Untreated (left) and treated (right) Vero cells in culture
(DP collection).
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of ruminants (mainly cattle). Moreover AE-VTEC of ser-
otypes O5:H-, O26:H11, O111:H- and O118:H16 can
also cause diarrhoea in less than 3 month-old calves
[1,4,12,14,21,23-25]. Besides the production of Vtx and of
AE lesions, other virulence properties of AE-VTEC
strains have not been formally identified yet, though
many candidates have been proposed more especially
regarding colonization factors of the human and rumi-
nant intestines [5,24,25].
Verotoxin-producing E. coli without attaching and
effacing properties
AE-negative VTEC (that we will further designated as
VTEC without suffix unless specific adherence factors are
known) can be subdivided into porcine, human and rumi-
nant strains. The porcine VTEC responsible for the
oedema disease syndrome in weaned piglets form a target
host specific group of strains belonging to specific sero-
types (like O138:K81, O139:K82, O141:K85) and producing
the Vtx2e variant (subtyping nomenclature established at
the 7th International Symposium on Shiga Toxin < Vero-
cytotoxin > -Producing Escherichia coli Infections, Buenos
A i r e s ,1 0t o1 3M a y2 0 0 9[ 2 6 ] )a n dt h eF 1 8t a r g e th o s ts p e -
cific adherence factor allowing the colonization of the por-
cine intestine [2,27]. These F18-VTEC will not be
discussed in this manuscript.
When infecting humans, VTEC can also be responsible
for HUS due to the production of Vtx. The clinically and
epidemiologically most important human VTEC, though
they only sporadically cause outbreaks, belong to the
O91:H21, O104:H21, and O113:H21 serotypes [22] (sero-
pathotype group C). Such VTEC can also produce several
additional virulence factors, including different adhesins
that can be involved in intestinal colonization of humans
[28,29]. In addition other VTEC serotypes, whose epide-
miological role is currently unknown, have been sporadi-
cally associated with either mild or no symptoms in
humans so far [22] (seropathotype group D). Finally
some VTEC serotypes have never been isolated from
humans [22] (seropathotype group E). All seropathotypes
of VTEC can be isolated from faeces of asymptomatic
ruminant carriers [28,30].
Enteroaggregative E. coli
The acronym EAggEC refers to E. coli strains character-
i z e db yas p e c i f i c“stacked brick” aggregative adherence
pattern on Hep-II [31,32], a cell line of human origin
(Figure 3). EAggEC represent emerging specific human
pathogens responsible for acute or persistent diarrhoea
in children and adults worldwide. EAggEC strains pro-
duce specific adhesins (Aggregative Adherence Fimbriae
or AAF) responsible for the adherence on Hep-II cells
and for the intestinal colonization. But EAggEC are a
heterogeneous group of strains in their properties and
whole virulence gene repertoires and not all seem to be
pathogens.
Dozens of EAggEC O:H serotypes have indeed been
described so far, but many EAggEC can not be typed,
because either they auto-agglutinate due to the production
of AAF adhesins or they produce still unidentified O anti-
gens. Moreover EAggEC can produce different combina-
tions of three toxins (the plasmid-encoded autotransporter
toxin Pet, the enteroaggregative heat-stable toxin EAST1,
and the Shigella enterotoxin ShET1). The actual role of
these toxins in pathogenesis is however unclear, since they
can also be produced by other pathogenic E. coli strains.
Today the highest correlation between the aggregative
adherence phenotype on cell culture and diarrhoea in
humans is the presence of the aggR gene coding for a tran-
scriptional regulator of the expression of several virulence-
associated genes [34-37].
The O104:H4 as compared to O157:H7 Verotoxin-
producing E. coli outbreaks
Characteristics of the O104:H4 E. coli strain
Although HC and HUS that are often observed during
AE-VTEC infections were reported as main clinical signs
during the German outbreak, the O104:H4 E. coli strain
isolated from patient stools was positive for the gene cod-
ing for Vtx2a (subtyping nomenclature established at the
7th International Symposium on Shiga Toxin < Verocy-
totoxin > -Producing Escherichia coli Infections, Buenos
Aires, 10 to 13 May 2009 [26]), and negative for genes
coding for the AE lesion [33,38]. Further genetic analysis
of this O104:H4 VTEC strain identified additional patho-
genic determinants, some typical of VTEC like the ter
gene cluster conferring tellurite resistance, but also
others typical of EAggEC like the aggR gene regulator,
the aafA gene encoding the AAF/I adhesin and the set1
gene encoding the ShET1 toxin. Conversely the ast1 gene
encoding the EAST1 toxin was absent [33,38]. The O104:
H4 outbreak strain is therefore a chimeric pathogenic
E. coli here designated as Agg-VTEC i.e. an enteroaggre-
gative Vtx-producing E. coli.
Such Agg-VTEC strains of serotype O104:H4 were
already isolated in Germany in two HUS cases in 2001,
but differed by some virulence factors, for instance the
presence of the ast1 gene [33]. Agg-VTEC have been
rarely described and they belonged to other serotypes,
like O111:H2 [39] and O86:H- [40]. Another unique
characteristic of the 2011 German O104:H4 Agg-VTEC
outbreak strain was the production of a CTX-M15
extended-spectrum b-lactamase (ESBL) [33]. On this
basis, several enrichment and selective agar plates were
used during the investigation of the outbreak, followed
by agglutination or molecular techniques for vtx, wzxO104
and/or fliCH4 genes [33,38,41]. However, selective media
Piérard et al. Veterinary Research 2012, 43:13
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only O104:H4 strains isolated in Germany in 2001 do not
possess, but also derivatives of the 2011 outbreak strain
lost the ESBL-encoding genes [33,42].
Reservoirs and transmission
In the first days of the outbreak, involvement of an AE-
VTEC strain was reported and ruminants were logically
suspected as source of contamination. Indeed, the pri-
mary sources and vehicles of O157:H7 AE-VTEC infec-
tions are ruminants, mainly cattle and sheep in which the
bacteria are not pathogenic [1,4,12,14,21,23-25]. Contam-
ination of humans occurs through very diverse vehicles
after direct or indirect faecal contamination, like meat
(generally undercooked ground beef), unpasteurised dairy
p r o d u c t s ,f r e s hv e g e t a b l e s ,f r u i t ,d r i n k i n go rs w i m m i n g
water and/or pet farms. Though secondary spread is also
common, humans represent a dead-end target host of
O157:H7 AE-VTEC and the source-sink epidemiological
model can be used [23]. Shedding of O157:H7 AE-VTEC
in children has a median duration of 13 days (range 2 to
62 days) in patients with diarrhoea or HC [43] and 21
days (range from 5 to 124 days) in patients with HUS
[43]. By contrast with Salmonella enterica serotype Typhi
no long-term carriage has been described [23].
Identification of the O104:H4 strain as an Agg-VTEC
radically modified the epidemiological perspective and
investigations. Indeed EAggEC are present in all human
populations all over the world but no animal reservoir
has been identified so far. E. coli strains displaying the
aggregative adherence pattern on cells in culture were
isolated from faeces of calves, piglets and horses suffering
diarrhoea in South America, but they were unrelated to
human EAggEC strains in their major phenotypic traits
and in their virulence genes, being negative a.o. for the
aggR and aaf genes [15,44,45]. In addition to being a fre-
quent cause of diarrhoea in children or adults worldwide
EAggEC have already been implicated in food-borne
diarrheic outbreaks in developed and developing coun-
tries after human-borne contamination during food
handling [4,34-37,46,47].
No data are currently available on the actual reservoir
of Agg-VTEC strains [38] but all epidemiological data
point to humans and the faecal-oral route as the most
probable primary source of contamination during the
German outbreak. The first case-control studies pointed
Figure 3 Aggregative “stacked-brick” adherence to cultured intestinal epithelial cells. Outbreak E. coli O104:H4 isolate LB226692 (A); an
enteroaggregative E. coli (EAggEC) strain (positive control) (B); HUSEC041 (C); HUSEC037 (negative control) (D). Reproduced from [33] with
permission (licence number 2775450359431, October 24, 2011).
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as potential vehicles [48]. However new epidemiological
investigations identified germinated sprouts as the infec-
tion source [49-51] though no bacteriological confirma-
tion has been issued until now. Further epidemiological
data traced the source of infection back to a lot of fenu-
greek seeds used by the producer of the germinated
sprouts in Germany and originating from Egypt as the
most probable origin of the O104:H4 Agg-VTEC strain
[49].
Fresh produce is increasingly recognized as vehicle of
food-borne pathogens and are often consumed as mixed
food products, making it difficult to identify the contam-
ination source [52]. Sprouted seeds were involved in
multiple Salmonella enterica and O157:H7 AE-VTEC
infections [53]. In particular, the massive outbreak of
O157:H7 AE-VTEC in schoolchildren in 1996 in Sakai,
Japan, was undoubtedly related to contaminated radish
sprouts, although bacteriological tests on food and seeds
remained all negative [54]. In their review on fresh fruit
and vegetables as vehicle for the transmission of human
pathogens, Berger et al. [52] emphasize an increasing
risk due to proliferation of pathogens during the proces-
sing and post-harvest handling procedures of contami-
nated seeds.
Clinical and epidemiological data
At the end of the outbreak, the Robert Koch Institute
[55] reported 3979 probable and confirmed cases includ-
ing 938 HUS cases and 3041 non-HUS cases (Table 2). A
total of 55 infected persons died, corresponding to 1.4%
of the reported cases. The case fatality rate was much
higher in HUS cases (3.7%) than in non-HUS cases
(0.54%). Most cases were recorded in Germany (3842
cases, 96.7%). The majority of patients from 14 other
European countries, USA and Canada, reported travel to
or contact with travellers to Germany. A notable excep-
tion are the 15 HUS cases during an event in Bègles, a
village in the region of Bordeaux, France, with no direct
or indirect contact with Germany, but who also con-
sumed germinated sprouts made from the same lot of
fenugreek seeds from Egypt, increasing the likelihood
that these fenugreek seeds are the actual original source
of infection [56]. Furthermore, Pulsed Field Gel Electro-
phoresis (PFGE) analysis of German and French isolates
showed identical profiles between all investigated isolates
[57].
T h es e v e r i t yo fi l l n e s sw a sm a r k e d l yh i g h e rd u r i n gt h e
O104:H4 Agg-VTEC outbreak with more than 20% of
HUS cases and 1.4% deaths as compared to average fig-
ures during O157:H7 AE-VTEC outbreaks with 7-10%
HUS cases affecting predominantly young children and
0.5% overall death rate (Table 2) [58]. Possible explana-
tions are (i) the involvement of an Agg-VTEC strain that
is a human-adapted pathogen and maybe a better gut
colonizer than O157:H7 AE-VTEC and (ii) the use of
antibiotics during the outbreak. Indeed though they are
generally contra-indicated during VTEC infections [21],
as toxin production can be induced by some of them
(like fluoroquinolones) [59], it can be assumed that anti-
biotics are commonly used during hospitalization for HC.
Since the O104:H4 Agg-VTEC strain produces an ESBL,
use of broad-spectrum beta-lactams might have contribu-
ted to the outgrowth of this strain in the gut.
The German outbreak by the O104:H4 Agg-VTEC dif-
fered from the classical O157:H7 AE-VTEC outbreaks by
several other epidemiological characteristics (Table 2)
[58]. The incidence of O157:H7 AE-VTEC is not negligi-
ble since 350 outbreaks were reported in the USA
between 1982 and 2002 and many sporadic cases were
recorded as well [21]. According to ECDC, the overall
notification rate in Europe was 0.66 cases per 100, 000
inhabitants in 2008 and remained unchanged over the
last few years [60]. By contrast, only a few sporadic cases
related to VTEC of serotype O104:H4 were reported
before the German outbreak and even less isolates were
identified as EAggEC [38]. This massive outbreak and
emergence of an Agg-VTEC of serotype O104:H4 was
therefore totally unexpected.T h ea g ea n dg e n d e rd i s t r i -
bution also represents a distinct contrast with O157:H7
AE-VTEC outbreaks: most affected cases were middle-
aged adults (median age was 43 years) with a predomi-
nance of women (68% of HUS and 58% of non-HUS
cases), whereas during O157:H7 AE-VTEC outbreaks
Table 2 Epidemiological and clinical characteristics of O104:H4 Agg-VTEC infections as compared to O157:H7 AE-VTEC
infections
AE-VTEC O157:H7 Agg-VTEC O104:H4
Incidence of sporadic cases Third bacterial cause of diarrhoea in developed countries Extremely rarely reported
Outbreaks Frequent (from a few to > 6000 cases) One outbreak (almost 4000 cases)
Age distribution Young children (elderly) Middle aged adults
Gender distribution Equal Predominance of female
Incubation 1 to 9 days (average 3-5 days) 8 days (interquartile range 7 to 9 days)
Progression to HUS 7-10% > 20%
Mortality 0.5% 1.4%
Piérard et al. Veterinary Research 2012, 43:13
http://www.veterinaryresearch.org/content/43/1/13
Page 7 of 12HUS occurs mainly in young children and in elderly peo-
ple equally in both sex [55]. This particular age and gen-
der distribution may reflect either relative efficacy of the
human gut colonization by this Agg-VTEC strain or,
more probably, dietary preferences, as already observed
during a particular spinach-associated O157:H7 AE-V-
TEC outbreak in the United States in 2006. Here too, the
majority of HUS patients were adult women in contrast
to the classical age and gender distribution during O157:
H7 AE-VTEC infections [61].
Virulence factors and host specificity of AE-VTEC and
Agg-VTEC
W h o l eg e n o m es e q u e n c ea n a l y s i so fV T E Cs e n s ulato
and EAggEC identified numerous genes coding for puta-
tive adherence factors to colonize the intestinal epithe-
lium and/or toxins to cause lesions on the host cells
[24,28,29,34-37]. Some of them most probably also
represent a basis of their host specificity either in dis-
ease (target host) or in carrier state (reservoir host).
Nevertheless, the actual roles in disease of only the Ver-
otoxins of VTEC sensu lato, the AE lesion of AE-VTEC,
and the AAF fimbrial adhesins of EAggEC have been
extensively studied.
The Verotoxins
In 1977, Konowalchuk et al. observed in vitro that culture
supernatants of some E. coli isolates produced a pro-
found cytotoxic effect on Vero cells [6]. The clinical sig-
nificance of Verotoxins (Vtx) remained obscure until
1983, when their association with HC and HUS was
established [62,63]. Two distinct Vtx families have been
described, Vtx1 and Vtx2. Vtx1 is nearly identical to the
Shiga toxin of Shigella dysenteriae serotype I and the
term Shiga toxin (Stx) was later proposed to design this
group of cytotoxins [7]. No consensus has been reached
in the scientific community and both terms can be used
interchangeably. According to the subtyping nomencla-
ture established at the 7th International Symposium on
Shiga Toxin < Verocytotoxin > -Producing Escherichia
coli Infections, Buenos Aires, 10 to 13 May 2009 [26],
three variant forms of Vtx1 and seven variant forms of
Vtx2 have been described, called Vtx1a, Vtx1c & Vtx1d
and Vtx2a through Vtx2g. Strains producing Vtx2a,
Vtx2c and/or Vtx2d are more often associated with HUS
[23,64]. Vtx2e is associated with the oedema disease in
swine and is only exceptionally produced by human iso-
lates [2,65]. The majority of Vtx are encoded by phage-
located genes that can be lost or acquired by other E. coli
not only in vitro but also in vivo [66-68].
Vtx are dimeric toxins comprising one A subunit,
responsible for the enzymatic activity and five B subu-
nits that bind to a cell surface receptor, Gb3 (Gb4 for
Vtx2e). In humans the Gb3 receptor is expressed at low
level by enterocytes and at high level by endothelial cells
in particular in the renal glomeruli. Vtx cross the intest-
inal epithelium by transcytosis through the enterocytes,
i.e. endocytosis followed exocytosis at the basal pole.
Vtx subsequently travel in the blood stream in associa-
tion with leucocytes and attach to receptors on the
endothelial cells. After internalization, the whole toxin is
transported retrogradely within endocytic vesicles to the
endoplasmic reticulum via the Golgi apparatus. There
the A subunit is translocated into the cytoplasm, enzy-
matically activated and reaches its target, the 28S ribo-
somal RNA. The protein synthesis is inhibited after
N - g l y c o s y l a t i o no fas p e c i f i ca d e n i n er e s i d u eo ft h e2 8 S
rRNA. By damaging the blood vessel wall, Vtx even-
tually provoke thrombotic microangiopathy, leading to
the three prominent features of HUS, haemolysis,
thrombocytopaenia and renal failure [12,21,24,69,70].
Though a few AE-VTEC serotypes (O5:H-, O26:H11,
O111:H-, O118:H16) can also cause diarrhoea in less
than 3 month-old calves and association of O157:H7
AE-VTEC with neonatal diarrhoea in calves has been
sporadically reported, there exists no report of HUS-like
syndrome in ruminants [2,12,14,21,23,24]. It has long
been hypothesised that the absence of receptors on enter-
ocytes [71] was the cause of this lack of Vtx toxicity in
cattle, but Gb3 has been recently detected on bovine
intestinal and renal cells [72]. A different intracellular
trafficking in ruminants localizes Vtx in lysosomes, lead-
ing to abrogation of transcytosis in enterocytes [73].
The AE lesion
Another important characteristic of AE-VTEC strains is
their ability to provoke the disappearance of the entero-
cyte microvilli and to intimately attach to their nude
cytoplasmic membrane (Figure 2). AE lesions are the
results of a profound dis- and re-organization of the
actin filaments of the eukaryotic cell skeleton [17,18,21].
As mentioned earlier, AE lesions are also induced by
EPEC strains that produce no Vtx [14,17,18] (Table 1).
A large bacterial chromosomal pathogenicity island, the
locus of enterocyte effacement (LEE), carries all (or
almost all according to the sero-pathotypes) genes neces-
sary for the formation of the AE lesion [17,18,21]. They
code for the proteins building up a type 3 secretion sys-
tem (T3SS) or needle-like injectisome apparatus, for type
3-secreted proteins or translocated effectors (whose
repertoires can be different according to the seropatho-
types) interacting through a phosphorylation and activa-
tion cascade with the cell cytoskeleton actin filaments
leading to the effacement of the enterocyte microvilli,
and for the intimin adhesin that is a bacterial outer mem-
brane protein responsible for the intimate (< 10 nm gap)
attachment of the E. coli to the enterocytes. The injecti-
some tip is embedded within the enterocyte cytoplasmic
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enterocytes, through which the effectors translocate into
the enterocyte. One of them is the Tir (Translocated Inti-
min Receptor) protein that can have different functions
after incorporation into the enterocyte cytoplasmic mem-
brane, including serving as a receptor for the intimin
adhesin [17,18,21].
Different types of intimin adhesins have been
described that differ in their amino acid carboxy-term-
inal sequences. These intimins are designated by Greek
letters and correlated to the AE-VTEC and EPEC sero-
types [18,74]. The intimin adhesin of O157:H7 AE-
VTEC strains belongs to the gamma type (Int-g). Since
the interaction between intimin and Tir is located in the
carboxy-terminal region of the intimin, the different
intimin types specifically interact with their cognate Tir
receptor [75,76]. Nevertheless this specific molecular
interaction does not fully explain host specificity and tis-
sue tropism.
The reservoir (ruminants) and target (humans) host
specificity and tissue tropism (jejunum, colon, rectum)
might therefore reside in the production of non-intimin
adhesins acting as primary colonization factors. Several
have been identified and their role studied, more espe-
cially on cells in culture [28]. In addition whole genome
sequencing of different AE-VTEC strains (especially
O157:H7) [77-80] revealed the presence of genes coding
for several putative fimbrial and non-fimbrial adhesins
[81]. But as a matter of fact the actual role of these
(putative) adhesins in the pathogenicity, host specificity
and tissue tropism of AE-VTEC still awaits full
characterization.
The AAF adhesins
The aggregative adherence phenotype of human EAggEC
strains to HEp-2 or HeLa cells in culture [31,32] is asso-
ciated with the production of four types of fimbrial adhe-
sins: AAF (Aggregative Adherence Fimbriae)/I, AAF/II,
AAF/III or Hda (HUS-associated Diffuse Adherence),
whose encoding genes (aaf and hda) are plasmid-located
[82-85]. If the three AAF adhesins are EAggEC-specific,
interestingly the hda gene is also present in HUS-asso-
ciated E. coli as its name indicates [83]. AAF fimbriae are
long thin and flexible fimbrial appendices of 2 to 3 nm in
diameter that are genetically distantly related to the large
Afimbrial Adhesin (AFA) family [86].
In vivo EAggEC not only adhere to enterocytes and to
the extracellular intestinal matrix, but also form mucoid
biofilms at the surface of the intestinal epithelium of the
terminal ileum and of the colon [37,87,88]. However the
precise mechanism by which EAggEC cause diarrhoea is
still not fully understood. Several putative additional viru-
lence factors, including different toxins as already men-
tioned, have been identified but none has yet been proved
as the actual cause of diarrhoea [37,87,89]. EAggEC actu-
ally form a heterogeneous group of strains harbouring dif-
ferent combinations of those putative virulence genes,
some of them being regarded as pathogens while others
not [34-37].
The highest correlation between this phenotype on
cell culture and diarrhoea in humans is the presence of
the aggR gene located on the same plasmid as the aaf
genes. AggR is a transcriptional activator regulating the
expression of several virulence-associated genes, includ-
ing the aaf genes [34-37]. Host specificity of EAggEC
for humans is most probably based on the AAF fimbrial
adhesins since all EAggEC isolated so far from animals
harbour no aaf gene [15].
General discussion
Many virulence-associated properties of pathogenic
E. coli are encoded by genes located on mobile genetic
elements, like plasmids, phages, transposons, and patho-
genicity islands. For instance, it has been observed that
Vtx-encoding phages can be acquired, or lost in vitro and
in vivo. Therefore in theory new combinations of viru-
lence factors and VTEC pathotypes may arise anytime
[66-68], rendering their nomenclature most difficult and
confusing. It is today accepted that the prototype O157:
H 7A E - V T E Cs t r a i no r i g i n a t e df r o ma nO 5 5 : H 7E P E C
strain by stepwise acquisition of VT-encoding phages
followed by acquisition or loss of other properties [90,91]
while AE-VTEC strains belonging to other serotypes fol-
lowed other evolutionary lineages [9,80,92,93]. Analysis
of the complete genome of the O104:H4 Agg-VTEC out-
b r e a ks t r a i na n do f7V t x - n e g a t i v eO 1 0 4 : H 4E A g g E C
strains actually confirmed that the outbreak strain is
derived from the latter strains by horizontal transfer of
Vtx-encoding genes [10,59,93].
Although one of them has until now strongly advo-
cated the distinction between EHEC, VTEC and EPEC
on the basis of the combination of Vtx and/or AE lesion
production [27], today the authors of this review manu-
script propose to change the nomenclature of Vtx-pro-
ducing E. coli. At first they suggest to only use the
acronym VTEC that refers to the production of Vtx and
to disregard the “EHEC” and related (atypical EHEC,
EHEC-like, EAHEC) acronyms [93] that refer to a clini-
cal condition. “EHEC” is even further confusing since
bloody diarrhoea is not always prominently present dur-
ing clinical manifestation and since this acronym is
actually used with various definitions in the scientific
and medical literature. The second step in the identifica-
tion would be to add a suffix to the acronym VTEC in
order to better describe the other virulence-associated
properties, more especially adherence properties [29]:
AE-VTEC for those producing AE lesion (like O157:H7
and other “EHEC” serotypes), Agg-VTEC for those
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VTEC for those producing the Saa afimbrial adhesin,
F18-VTEC for those associated with oedema disease in
piglets, etc. Such nomenclature not only focuses on the
main virulence-associated properties of VTEC, but also
leaves the options open to include new combinations
that might arise in the future. Moreover these acronyms
can easily be included in the seropathotype grouping
scheme of Karmali et al. [22]: for instance strains of ser-
opathotype groups A and B are AE-VTEC; those of
group C are either AE-VTEC or Saa-VTEC or the new-
comer O104:H4 Agg-VTEC, etc. In addition, the com-
munication about source and vehicle of contamination
by veterinarians, medical doctors, scientists, journalists
and politicians to the general public would be facilitated
since an outbreak caused by an AE-VTEC strain would
most probably find its origin in ruminant faeces, while
an outbreak by another type of VTEC less probably.
Finally, some questions remain unanswered about the
O104:H4 Agg-VTEC outbreak. The high proportion of
adult patients developing HUS as compared with the
young children predominantly infected with O157:H7 AE-
VTEC, suggests that the Vtx2a crossed the intestinal
mucosa more efficiently and/or in higher amounts, maybe
as a consequence of the colonization of different intestinal
segment(s) by the O104:H4 Agg-VTEC, although the
actual reason remains unidentified. And the particular
gender and age distribution also suggests that some dietary
preferences could be a crucial factor. Another issue is the
lack of investigations in Egypt. If it is confirmed that the
fenugreek seeds are the origin of infection, it would be
appealing to investigate how they were contaminated.
Further, the survival and multiplication of the bacteria
during sprouting and the means how to control the bac-
terial proliferation should be studied.
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